Insider Transactions by Thomas, McNerney & Partners II L.P.

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
CRXTClarus Therapeutics Holdings, Inc.Thomas, McNerney & Partners II L.P.10% OwnerApr 20, 2022Sale$2.533,752,9129,494,867958,989Apr 25, 2022, 05:17 PM
CRXTCLARUS THERAPEUTICS INCThomas, McNerney & Partners II L.P.10% OwnerApr 20, 2022Sale$2.533,752,9129,494,867958,989Apr 21, 2022, 07:04 PM
CASMCAS MEDICAL SYSTEMS INCThomas, McNerney & Partners II L.P.10% OwnerApr 18, 2019Option Exercise$2.39111,847267,202119,872Apr 22, 2019, 02:14 PM
CASMCAS MEDICAL SYSTEMS INCThomas, McNerney & Partners II L.P.10% OwnerApr 18, 2019Option Exercise$2.45119,872293,6860Apr 22, 2019, 02:14 PM
CASMCAS MEDICAL SYSTEMS INCThomas, McNerney & Partners II L.P.10% OwnerApr 18, 2019Option Exercise$2.3910,709,14925,584,15612,300,186Apr 22, 2019, 02:14 PM
CASMCAS MEDICAL SYSTEMS INCThomas, McNerney & Partners II L.P.10% OwnerApr 18, 2019Option Exercise$2.4512,300,18630,135,4560Apr 22, 2019, 02:14 PM
CASMCAS MEDICAL SYSTEMS INCThomas, McNerney & Partners II L.P.10% OwnerApr 18, 2019Option Exercise$2.3938,00690,79643,944Apr 22, 2019, 02:14 PM
CASMCAS MEDICAL SYSTEMS INCThomas, McNerney & Partners II L.P.10% OwnerApr 18, 2019Option Exercise$2.4543,944107,6630Apr 22, 2019, 02:14 PM
CASMCAS MEDICAL SYSTEMS INCThomas, McNerney & Partners II L.P.10% OwnerFeb 11, 2015Buy$1.308,02510,4328,025Feb 13, 2015, 04:15 PM
CASMCAS MEDICAL SYSTEMS INCThomas, McNerney & Partners II L.P.10% OwnerFeb 11, 2015Buy$1.301,591,0372,068,3481,632,945Feb 13, 2015, 04:15 PM
CASMCAS MEDICAL SYSTEMS INCThomas, McNerney & Partners II L.P.10% OwnerFeb 11, 2015Buy$1.305,9387,7195,938Feb 13, 2015, 04:15 PM
ASPXAuspex Pharmaceuticals, Inc.Thomas, McNerney & Partners II L.P.10% OwnerJan 28, 2015Sale$53.11730,00038,770,3004,835,731Jan 30, 2015, 02:17 PM
ASPXAuspex Pharmaceuticals, Inc.Thomas, McNerney & Partners II L.P.DirectorOct 09, 2014Option Exercise$23.899,771233,3805,270,604Oct 14, 2014, 11:12 AM
ASPXAuspex Pharmaceuticals, Inc.Thomas, McNerney & Partners II L.P.DirectorOct 09, 2014Option Exercise$3.8860,151233,3265,280,375Oct 14, 2014, 11:12 AM
ASPXAuspex Pharmaceuticals, Inc.Thomas, McNerney & Partners II L.P.DirectorMay 14, 2014Option Exercise$3.8865,839255,3895,232,624Sep 19, 2014, 12:28 PM
ASPXAuspex Pharmaceuticals, Inc.Thomas, McNerney & Partners II L.P.DirectorMay 14, 2014Option Exercise$20598.0012,400255,415,2005,220,224Sep 19, 2014, 12:28 PM
ASPXAuspex Pharmaceuticals, Inc.Thomas, McNerney & Partners II L.P.10% OwnerMay 14, 2014Sale$20.6012,400255,4155,220,224Sep 09, 2014, 06:50 PM
ASPXAuspex Pharmaceuticals, Inc.Thomas, McNerney & Partners II L.P.10% OwnerMay 14, 2014Option Exercise$3.8865,839255,3895,232,624Sep 09, 2014, 06:50 PM
ASPXAuspex Pharmaceuticals, Inc.Thomas, McNerney & Partners II L.P.10% OwnerFeb 10, 2014Buy$12.0083,3341,000,0085,166,785Feb 12, 2014, 06:38 PM
OCRXOcera Therapeutics, Inc.Thomas, McNerney & Partners II L.P.10% OwnerJul 15, 2013Option Exercise$6.001,751,39310,508,3581,751,393Jul 17, 2013, 06:41 PM
OCRXOcera Therapeutics, Inc.Thomas, McNerney & Partners II L.P.10% OwnerJul 15, 2013Option Exercise$6.00687,1764,123,056687,176Jul 17, 2013, 06:41 PM
ZGNXZOGENIX, INC.Thomas, McNerney & Partners II L.P.See Footnote (10)Nov 29, 2010Buy$4.00524,2292,096,9161,407,316Nov 30, 2010, 12:26 PM
ZGNXZOGENIX, INC.Thomas, McNerney & Partners II L.P.See Footnote (10)Nov 29, 2010Buy$4.001,9677,8685,280Nov 30, 2010, 12:26 PM
ZGNXZOGENIX, INC.Thomas, McNerney & Partners II L.P.See Footnote (10)Nov 29, 2010Buy$4.005,47621,90414,700Nov 30, 2010, 12:26 PM
ZGNXZOGENIX, INC.Thomas, McNerney & Partners II L.P.See Footnote (10)Nov 29, 2010Buy$4.003,17812,71256,094Nov 29, 2010, 09:43 PM
ZGNXZOGENIX, INC.Thomas, McNerney & Partners II L.P.See Footnote (10)Nov 29, 2010Buy$4.00173,399693,5961,663,193Nov 29, 2010, 09:43 PM
ZGNXZOGENIX, INC.Thomas, McNerney & Partners II L.P.See Footnote (10)Nov 29, 2010Buy$4.006472,5886,297Nov 29, 2010, 09:43 PM